NextCell Pharma publishes Interim Report 1 2021/2022
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 1 for the period September 1, 2021 - November 30, 2021 The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-reportNextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.First quarter (2021-09-01 until 2021-11-30) ● Operating income amounted to TSEK 1 347 (1 148).● Operating result amounted to TSEK -6 472 (-5 473).● Earnings per share* amounted to